|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2011-6-9
|
|
pubmed:abstractText |
Familial partial lipodystrophy (FPLD) is a rare metabolic disorder with clinical features that may not be readily recognised. As FPLD patients require a specific therapeutic approach, early identification is warranted. In the present study we aimed to identify cases of FPLD among non-obese patients with type 2 diabetes mellitus and marked insulin resistance.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1432-0428
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1639-44
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21479595-Adult,
pubmed-meshheading:21479595-Aged,
pubmed-meshheading:21479595-Diabetes Mellitus, Type 2,
pubmed-meshheading:21479595-Female,
pubmed-meshheading:21479595-Humans,
pubmed-meshheading:21479595-Insulin,
pubmed-meshheading:21479595-Insulin Resistance,
pubmed-meshheading:21479595-Lipodystrophy, Familial Partial,
pubmed-meshheading:21479595-Male,
pubmed-meshheading:21479595-Middle Aged,
pubmed-meshheading:21479595-Mutation,
pubmed-meshheading:21479595-PPAR gamma
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPAR? mutation (Y151C).
|
|
pubmed:affiliation |
Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
